UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061488
Receipt number R000070350
Scientific Title Self-care behaviors and healthcare app utilization for diabetes prevention and management: a mixed-methods study using questionnaires and log data
Date of disclosure of the study information 2026/05/08
Last modified on 2026/05/08 11:00:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Self-care behaviors and healthcare app utilization for diabetes prevention and management: a mixed-methods study using questionnaires and log data

Acronym

Self-care behaviors and healthcare app utilization for diabetes prevention and management: a mixed-methods study using questionnaires and log data

Scientific Title

Self-care behaviors and healthcare app utilization for diabetes prevention and management: a mixed-methods study using questionnaires and log data

Scientific Title:Acronym

Self-care behaviors and healthcare app utilization for diabetes prevention and management: a mixed-methods study using questionnaires and log data

Region

Japan


Condition

Condition

Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the current status of self-care behaviors and healthcare app utilization for diabetes prevention and management in Japan.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1.Self-care behaviors aimed at diabetes prevention and management (health maintenance)
2.Smartphone healthcare apps utilization aimed at diabetes prevention and management (health maintenance)

Key secondary outcomes

1.Reasons for not using / discontinuing use / using smartphone healthcare apps aimed at diabetes prevention and management (health maintenance)
2.Participation rate in specific health guidance and diabetes prevention programs


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

[Healthy individuals]
1.Aged 30-74 years
2.Underwent health checkup in the past year
3.Able to confirm health checkup results
4.Fasting blood glucose < 110 mg/dl and HbA1c < 6.5%
5.Consented to participate in the study

[Pre-diabetes]
1.Aged 30-74 years
2.Underwent health checkup in the past year
3.Able to confirm health checkup results
4.Fasting blood glucose 110 to <126 mg/dl and HbA1c < 6.5%
5.Consented to participate in the study

[Diabetic patients]
1.Aged 30-74 years
2.Currently receiving treatment for diabetes
3.Consented to participate in the study

Key exclusion criteria

[Healthy individuals and Pre-diabetes]
1.History of diabetes or dementia
2.Currently taking blood glucose lowering medication, or unknown medication status
3.Hospitalized in the past year
4.Missing outdoor activity log info for the past year or smartphone healthcare app info

[Diabetic patients]
1.History of dementia
2.Hospitalized in the past year
3.Missing outdoor activity log info for the past year or smartphone healthcare app info

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Ryosuke
Middle name
Last name Nishi

Organization

INTAGE Healthcare Inc.

Division name

Value & Access Department

Zip code

101-0062

Address

13F Ochanomizu SolaCity, 4-6 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan

TEL

03-5294-8393

Email

nishi-r@intage.com


Public contact

Name of contact person

1st name Ryosuke
Middle name
Last name Nishi

Organization

INTAGE Healthcare Inc.

Division name

Value & Access Department

Zip code

101-0062

Address

13F Ochanomizu SolaCity, 4-6 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan

TEL

03-5294-8393

Homepage URL


Email

nishi-r@intage.com


Sponsor or person

Institute

INTAGE Healthcare Inc.

Institute

Department

Personal name

Ryosuke Nishi


Funding Source

Organization

INTAGE Healthcare Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

PLAMED Inc.

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 09 Day

Date of IRB

2026 Year 04 Month 16 Day

Anticipated trial start date

2026 Year 05 Month 08 Day

Last follow-up date

2026 Year 05 Month 14 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2026 Year 05 Month 08 Day

Last modified on

2026 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070350